52W Range | $3.10-$63.45 |
Market Cap | $7.4M |
Shares Short | 19,840 |
Revenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$30.78 |
Yahoo Finance • 11 days ago
Yahoo Finance • 12 days ago
Yahoo Finance • 13 days ago
CEO | Mr. Ilan Hadar M.B.A. |
CFO | Ms. Mirit Horenshtein Hadar |
Address | The Goldyne Savad Inst. of Gene Therapy, Jerusalem, Israel, 9112001 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 11 |